
Tilson: AIG Is No V...


| Price and Volume | |
|---|---|
| Recent Price | 9.07 |
| 52 Week High | 9.98 |
| 52 Week Low | 5.90 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 0.27 |
| Share Related Items | |
| Mkt Cap (Mil) | 189.85 |
| Shares Out (Mil) | 20.93 |
| Float (Mil) | 19.11 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.70 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.15 |
| Total Debt / Equity | 0.21 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.63 |
| Price/Book | 4.92 |
| Price/Cash Flow | -25.20 |
| Per Share Data | |
| Earnings | -0.47 |
| Sales | 3.45 |
| Book Value | 1.84 |
| Cash Flow | -0.36 |
| Business Summary | |
|---|---|
| AtriCure, Inc., is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. | |
| General Information | |
| 6217 Centre Park Drive
West Chester, OH 45069 |
|
| www.atricure.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 230 | |
| CEO: Michael H. Carrel | |
| Short Interest | |
| Current Month (Mil) | 0.50 |
| Previous Month (Mil) | 0.47 |
| Short Interest Ratio (Days) | 8.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -16.30 |
| Return on Investments | -21.00 |
| Profitability | |
| Gross Margin | 73.80 |
| EBIT Margin | -9.80 |
| Profit Margin | -13.10 |